Physicians in California can order Immunovia’s Immray PanCan-d blood test for the early detection of pancreatic cancer in their patients.
The California Department of Public Health has granted Immunovia a clinical and public health laboratory license for the test, Immunovia said Thursday.
Commercialization of the laboratory-developed test (LDT) was initiated in the U.S. in August 2021.
